Translational Development of a Drug Candidate for Neurodegenerative Disorders

Goal

To support preclinical development and a first-in-man (Phase I) clinical trial of an attractive drug candidate, discovered at Trinity College Dublin, for potential treatment of neurodegenerative disorders, including ageing-related conditions such as Alzheimer’s disease.